Canrenone
規格
976-71-6CAS番号
213-554-5EC番号
(8R,9S,10R,13S,14S,17R)-10,13-dimethylspiro[2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-17,5'-oxolane]-2',3-dioneIUPAC名
C22H28O3化学式
340.5 g/mol分子量
CANRENONE; 976-71-6; Aldadiene; SC-9376; Canrenonum; DTXSID3045930; Spironolactone metabolite m1; 78O20X9J0U; SC9376; NSC-261713; DTXCID1025930; Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, gamma-lactone (17alpha)-; (1'S,2R,2'R,10'R,11'S,15'S)-2',15'-dimethylspiro(oxolane-2,14'-tetracyclo(8.7.0.0^(2,7).0^(11,15))heptadecane)-6',8'-diene-5,5'-dione; (1'S,2R,2'R,10'R,11'S,15'S)-2',15'-dimethylspiro[oxolane-2,14'-tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecane]-6',8'-diene-5,5'-dione; RefChem:123246; R.P., 11614; Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, gamma-lactone, (17alpha)-; 213-554-5; SC 9376; Phanurane; Luvion; Canrenona; (8R,9S,10R,13S,14S,17R)-10,13-dimethylspiro[2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-17,5'-oxolane]-2',3-dione; MFCD00071735; Canrenone (USAN); 17-Hydroxy-3-oxo-17alpha-pregna-4,6-diene-21-carboxylic acid gamma-lactone; CANRENONE [USAN]; NSC 261713; Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, g-lactone,(17a)-; Aldadiene (VAN); (10R,13S,17R)-10,13-dimethylspiro[2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-17,5'-oxolane]-2',3-dione; Canrenone [USAN:INN]; Canrenonum [INN-Latin]; Canrenona [INN-Spanish]; (2'R,8R,9S,10R,13S,14S)-10,13-dimethyl-1,8,9,10,11,12,13,14,15,16-decahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-3,5'(2H,4'H)-dione; CAS-976-71-6; SMR000539206; 11614 R. P.; EINECS 213-554-5; BRN 0046602; Aldadiene;SC9376;SC14266; Spiroletan; Spironolactone EP impurity F; UNII-78O20X9J0U; 11614 R.P; Phanurane;; Contaren;; Canrenone CRS; Luvion;; 20-Spiroxa-4,6-diene-3,21-dione; 3',4'-Dihydrospiro[androst-4,6-diene-17,2'(5'H)-furan]-3,5'-dione (Canrenone); NCGC00095148-01; (8R,9S,10R,13S,14S,17R)-10,13-dimethyl-1,8,9,10,11,12,13,14,15,16-decahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-3,5'(2H,4'H)-dione; Canrenone (Standard); Canrenone - 95%; CANRENONE [INN]; CANRENONE [MI]; 17alpha-(2-Carboxyethyl)-17beta-hydroxyandrosta-4,6-dien-3-one lactone; CANRENONE [MART.]; EC 213-554-5; CANRENONE [WHO-DD]; SCHEMBL19560; 5-17-11-00476 (Beilstein Handbook Reference); MLS001163777; MLS001304014; MLS001304154; Canrenone - Bio-X trade mark; orb1310694; orb3025819; Canrenone, >=97% (HPLC); CHEMBL1463345; GTPL13963; HY-B1438R; CHEBI:135445; Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, .gamma.-lactone (17.alpha.)-; HMS2090K21; HMS2870D16; HMS3715A05; HY-B1438; Tox21_111451; (17a)-17-Hydroxy-3-oxopregna-4; BBL010921; EBC-13716; STK801874; AKOS005622473; Tox21_111451_1; 6-diene-21-carboxylic acid ?-lactone; AC-1323; CCG-220962; DB12221; FC19670; MSK000847-100A; 17alpha-Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, gamma-lactone; MSK000847-1000A; NCGC00263479-01; NCGC00263479-02; NCGC00263479-06; (1R,3aS,3bR,9aR,9bS,11aS)-9a,11a-dimethyl-2,3,3a,3b,7,8,9,9a,9b,10,11,11a-dodecahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxolane]-5',7-dione; AS-13160; BC300044; FC166171; CS-0013142; NS00010904; Canrenone Solution in Acetonitrile, 100ug/mL; Canrenone Solution in Acetonitrile, 1000ug/mL; D03363; D95826; EN300-123063; SPIRONOLACTONE IMPURITY F [EP IMPURITY]; AB00825212-04; AB00825212-06; SR-01000813823; Q5033475; SR-01000813823-2; 17b-Hydroxy-3-oxopregna-4,6-diene-21-carboxylic acid; Z1546624239; Canrenone, European Pharmacopoeia (EP) Reference Standard; Eplerenone Impurity - Canrenone; Spironolactone EP Impurity F; 17-Hydroxy-3-oxo-17a-pregna-4,6-diene-21-carboxylic acid lactone; 17a-(2-Carboxyethyl)-17b-hydroxyandrosta-4,6-dien-3-one lactone; 17a-2-Carboxyethyl-17b-hydroxyandrosta-4,6-dien-3-one lacton e; (7a)-17-Hydroxy-3-oxo-pregna-4,6-diene-21-carboxylic acid gamma-lactone; 17-Hydroxy-3-oxo-17a-pregna-4,6-diene-21-carboxylic acid g-lactone; 3'-(3-Oxo-17b-hydroxyandrosta-4,6-dien-17a-yl)-propionic acid lactone; 3-(17b-Hydroxy-3-oxoandrosta-4,6-dien-17a-yl)propionic acid g-lactone; 3-(17b-Hydroxy-3-oxoandrosta-4,6-dien-17a-yl)propionic acid lactone; 3-(3-Oxo-17b-hydroxy-4,6-androstadien-17a-yl)propionic acid g-lactone; 2R)-3,4-DIHYDRO-5H-SPIRO(ANDROST-4,6-DIENE-17,2-FURAN)-3,5-DIONE; (1R,3aS,3bR,9aR,9bS,11aS)-9a,11a-Dimethyl-2,3,3a,8,9,9a,9b,10,11,11a-decahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxolane]-5',7(3bH)-dione; (8R,9S,10R,13S,14S,17R)-10,13-dimethyl-1,3',4',8,9,10,11,12,13,14,15,16-dodecahydro-5'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-3,5'(2H)-dione; (8R,9S,10R,13S,14S,17R)-10,13-dimethylspiro[2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-17,5'-tetrahydrofuran]-2',3-dione別名
